FX 2149 is a GTP-binding inhibitor that potently inhibits LRRK2 GTP binding and kinase activity in vitro and attenuates the toxic effects of LRRK2 in Parkinsons disease models.
Molecular Weight:
319.38
Purity:
99.94%
CAS Number:
[1842427-90-0]
Formula:
C15H17N3O3S
Target:
LRRK2
T212761
* VAT and and shipping costs not included. Errors and price changes excepted
